Back to CPRX overview

CPRX Catalyst Pharmaceuticals PE ratio, current and historical analysis

The current P/E ratio for Catalyst Pharmaceuticals stock as of Jun 14, 2024 is 25.1. This is calculated based on the current EPS of $0.6 and the stock price of $15.06 per share. The PE ratio has increased by 20% from the past four quarters average of 20.9.

CPRX PE ratio history

How has CPRX's PE ratio performed in the past

The average historical PE ratio of Catalyst Pharmaceuticals for the last five years is 16.98. The current price-to-earnings ratio of 25.1 is 48% more than the historical average. In the past five years, CPRX's PE ratio reached its highest point in the Sep 2019 quarter at 59, when the stock price was $5.31 and the EPS was $0.09. The lowest point was recorded in the Sep 2020 quarter, when it reached 4.3 with a price of $2.97 and an EPS of $0.69.

Average
16.98
Median
13.25
Minimum
4.3
Maximum
59

Catalyst Pharmaceuticals PE ratio by year

Maximum annual increase: 284.05% in 2021

Maximum annual decrease: -61.65% in 2020

Year PE ratio Change
2023 25.09 7.91%
2022 23.25 30.47%
2021 17.82 284.05%
2020 4.64 -61.65%
2019 12.1 N/A
2018 N/A N/A
2017 N/A N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A

CPRX average PE ratio chart

What is the average PE ratio of CPRX for the past years

The current PE ratio of CPRX is above its 3, 5 and 10-year historical averages.

3-year avg
17.94
5-year avg
16.98
10-year avg
16.98
15-year avg
16.98

CPRX PE vs peers

What is CPRX's PE ratio compared to its peers

When compared to its peers ABT and BMRN, CPRX's PE ratio is lower, but it is higher than JNJ's.

Stock name PE ratio Market cap
JNJ Johnson & Johnson 9.54 $350.27B
CPRX Catalyst Pharmaceuticals Inc 25.1 $1.78B
ABT Abbott Laboratories 32.1 $180.37B
BMRN Biomarin Pharmaceutical Inc 76.61 $15.86B
SRPT Sarepta Therapeutics Inc 299.61 $11.61B
PFE Pfizer Inc N/A $156B

Frequently asked questions

What is Catalyst Pharmaceuticals's PE ratio?

CPRX stock has a price to earnings ratio of 25.1 as of Jun 14, 2024.

What is the 3-year average PE ratio for Catalyst Pharmaceuticals (CPRX)?

As an average over the last 3 years, CPRX stock has a PE ratio of 17.94.

What is the 5-year average PE ratio for Catalyst Pharmaceuticals (CPRX)?

As an average over the last 5 years, CPRX stock has a PE ratio of 16.98.

What is the highest PE ratio for CPRX?

Over the last five years, the quarterly PE ratio reached a historic high of 59 in the Sep 2019 quarter.

How does the current PE ratio for CPRX compare to its historical average?

The current price to earnings ratio of CPRX is 48% higher than the 5-year historical average.

How is CPRX's PE ratio calculated (Catalyst Pharmaceuticals PE ratio formula)?

The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Jun 14, 2024), Catalyst Pharmaceuticals's stock price is $15.06. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $0.6. Therefore, Catalyst Pharmaceuticals's price to earnings ratio for today is 25.1. PE RATIO(25.1) = STOCK PRICE($15.06) / TTM EPS($0.6)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.